Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metreleptin in Partial Lipodystrophy
NCT06484868Phase 4Recruiting
- Sponsor
- Amryt Pharma
- Start
- Feb 2024
- Primary completion
- Feb 2028
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 4 trial of metreleptin in partial lipodystrophy, sponsored by Amryt Pharma. Started Feb 2024; status: recruiting.
02
Drugs
metreleptin
03
Conditions
partial lipodystrophy
Beyond the preview
Go deeper on NCT06484868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06484868.